Symbyax Birth Defects

Symbyax May Cause Congenital Birth Defects

Symbyax is a selective serotonin reputake inhibitor (SSRI) antidepressant drug; it was developed by Eli Lilly and Company to treat episodes of bipolar disorder and treatment-resistant disorder. In 2003, the United States Food and Drug Administration (FDA) first approved Symbyax for the treatment of bipolar disorder, and later, in 2009, the FDA approved Symbyax for the treatment of treatment-resistant disorder.

Although the FDA has approved Symbyax, the drug has recently come under scrutiny for increasing the chances of pregnant women giving birth to infants with birth defects.

Possible Symbax Birth Defects

Symbyax has been linked with the potential to cause congenital birth defects such as abdominal defect, cranial defects, heart defects, and persistent pulmonary hypertension of newborns (PPHN).

The possible congenital heart defects are often treatable through surgery if they are caught early on in the infant’s life. However, multiple surgeries may be necessary in order to correct the defect. The following heart defects have been linked with Symbyax and other similar SSRI drugs:

• Coarctation of the aorta
• Hypoplastic left heart syndrome
• Heart valve abnormity
• Atrial septal defect
• Ventricular septal defect
• Patent ductus arteriosus

PPHN is a condition that occurs as result of low blood pressure in the lungs’ blood vessels – which causes the heart’s blood pressure to rise. As a result, the oxygen levels throughout the body’s bloodstream to be low.

Starting a Symbyax Lawsuit

Eli Lilly and Company manufactured and sold a product to doctors and patients without providing a sufficient amount of warning regarding potential side effects including congenital birth defects – rendering the pharmaceutical company legally and financially responsible for any suffering of victims.

If you or someone you know has taken Symbyax while pregnant and given birth to a child with Symbyax birth defects, please call 1-888-480-1123 to speak with a Chaffin Luhana, LLP lawyer regarding a potential Symbyax lawsuit. The call is free and confidential, and you may find that you are eligible for compensation from Eli Lilly and Company. A Chaffin Luhana Symbyax lawyer is standing by, prepared to advocate for your rights through a Symbax lawsuit.